Thiosulfate Sulfurtransferase 5 (SSEA-5) anticorps

N° du produit ABIN7469616

Cet anticorps Souris Monoclonal détecte spécifiquement Thiosulfate Sulfurtransferase 5 dans FACS, ICC, IF et IHC. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Thiosulfate Sulfurtransferase 5 (SSEA-5) anticorps (ABIN7469616)

Antigène: Thiosulfate Sulfurtransferase 5 (SSEA-5)

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC)

Clone: 8-00E-11

Détail du produit

Réactivité croisée: Humain

Purification: Protein G affinity purified

Immunogène: Undifferentiated human embryonic stem cells

Isotype: IgG

Information d'application

Indications d'application: ICC/IF: 1:50-1:1000. FACS: 1:50. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS, No Preservative

Agent conservateur: Without preservative

Stock: 4 °C,-20 °C

Stockage commentaire: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Détail du antigène

Antigène: Thiosulfate Sulfurtransferase 5 (SSEA-5)

Autre désignation: SSEA-5

Sujet:

Synonyms: Stage-Specific Embryonic Antigen-5 , SSEA-5

Background: Stage-specific embryonic antigen (SSEA)-5 is an H type-1 glycan that is highly and specifically expressed on human embryonic stem cells (hESCs), the human blastocyst inner cell mass and undifferentiated human pluripotent stem cells (hPSCs). Expression of SSEA-5 in hESCs and hPSCs rapidly decreases upon differentiation and is considered an indicator of undifferentiated PSCs. This SSEA-5 antibody is capable of identifying undifferentiated pluripotent stem cells in heterogeneous populations, and when used in conjunction with other pluripotency surface markers (CD9 and CD90 or CD50 and CD200), it can be used to immunodeplete residual teratoma-causing cells from incompletely differentiated embryonic stem cell cultures.